ArticleMolecular metabolism2017

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.

Tsuyoshi Yanagimachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.